1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZMYM4 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA BEND5 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA PARP1 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA CEP162 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA SERINC3 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA ZMYM3 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA FAM193A CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA USP37 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA ATP6V1G2-DDX39B CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA TPR CTRPv2 pan-cancer AAC 0.17 2e-07
Download CSV